Daiichi Jitsugyo and Agroludens Launch Large-Scale Demonstration Facility for Rice-Based Mycoprotein Commercialization
Daiichi Jitsugyo and Agroludens have launched a large-scale demonstration facility at the Nasu plant in Tochigi Prefecture to commercialize rice-derived mycoprotein and bioethanol.
📋 Article Processing Timeline
- 📰 Published: June 1, 2026 at 10:00
- 🔍 Collected: June 1, 2026 at 10:35 (35 min after Published)
- 🤖 AI Analyzed: June 1, 2026 at 18:59 (8h 23m after Collected)
Daiichi Jitsugyo Co., Ltd. and Agroludens Inc. have begun operations of a large-scale technical demonstration facility at the Agroludens Nasu plant in Otawara City, Tochigi Prefecture, aimed at the commercialization of rice-derived mycoprotein and bioethanol. The two companies formed a strategic partnership in 2022 to develop proprietary technology for co-producing mycoprotein and bioethanol from rice. This facility serves as a hub for scale-up verification and will form the basis for future commercial plant design. The companies aim to produce 5,000 tons of mycoprotein annually and are considering global expansion.
FAQ
Can this technology be applied to agriculture in Taiwan?
Since it uses rice as a raw material, it has high technical compatibility with Taiwan's rice-growing industry and holds potential for future application.